Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2009 02:30 ET | Source: Active Biotech

Årsstämma i Active Biotech AB

I enlighet med styrelsens förslag beslöts att ingen utdelning skulle lämnas. I enlighet med valberedningens förslag omvaldes styrelseledamöterna Mats Arnhög, Klas Kärre, Magnhild Sandberg,...
May 08, 2009 02:30 ET | Source: Active Biotech

Annual General Meeting of Active Biotech AB

In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. In accordance with the Election Committee's proposal, the Board members Mats Arnhög, Klas...
April 28, 2009 09:00 ET | Source: Active Biotech

NEW DATA ILLUSTRATE NOVEL MECHANISM OF ACTION OF LAQUINIMOD, AN ORAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS

Contact: Elana HolzmanKevin Mannix Teva Pharmaceutical Industries Ltd.Teva North America +972-(3)-926-7554+1-(215)-591-8912 Contact: Tomas LeandersonGöran Forsberg ...
April 28, 2009 09:00 ET | Source: Active Biotech

NYA RÖN KRING VERKNINGSMEKANISMEN FÖR LAQUINIMOD, EN NY ORAL BEHANDLING AV MULTIPEL SKLEROS

Kontakt: Elana Holzman Teva Pharmaceutical Industries...
April 28, 2009 02:30 ET | Source: Active Biotech

Active Biotech presents S100A9 as a target for quinoline compounds

The details about the molecules and mechanisms underlying the development of autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, are largely unknown. In this...
April 28, 2009 02:30 ET | Source: Active Biotech

Active Biotech presenterar S100A9 som en målmolekyl för quinolinsubstanser

Detaljerna kring vilka molekyler och mekanismer som ligger bakom utvecklingen av autoimmuna sjukdomar, såsom multipel skleros och systemisk lupus erythematosus, är i stor utsträckning...
April 23, 2009 02:30 ET | Source: Active Biotech

Active Biotech AB Interim report January-March 2009

For further information, please contact: Tomas LeandersonPresident and CEOTel: +46 (0)46-19 20 95 Göran Forsberg VP Investor Relations & Business Development...
April 23, 2009 02:30 ET | Source: Active Biotech

Active Biotech AB Delårsrapport januari-mars 2009

För ytterligare information, vänligen kontakta: Tomas LeandersonVDTfn 046-19 20 95 Göran Forsberg VP Investor Relations & Business Development Tfn 046-19...
April 06, 2009 02:32 ET | Source: Active Biotech

Årsredovisning 2008 Active Biotech AB (publ)

Active Biotechs årsredovisning för 2008 finns nu tillgänglig på www.activebiotech.com. Årsredovisningen kommer enbart att distribueras digitalt. Lund den 6 april...
April 06, 2009 02:32 ET | Source: Active Biotech

Annual Report 2008 Active Biotech AB (publ)

Active Biotech's Annual Report 2008 is now available for download at http://www.activebiotech.com. The Annual Report will only be digitally distributed. Lund, April...